The need for a correct oxygen-ozone autohemotherapy (O
3
-AHT) in patients with mild to moderate COVID-19 pneumonia
Intern Emerg Med
.
2021 Apr;16(3):793-794.
doi: 10.1007/s11739-020-02592-w.
Epub 2021 Jan 5.
Authors
Salvatore Chirumbolo
1
,
Sergio Pandolfi
2
,
Luigi Valdenassi
2
,
Dario Bertossi
3
,
Marianno Franzini
2
Affiliations
1
Department of Neurosciences, Biomedicine and Movement Sciences, Strada Le Grazie 9, 37134, Verona, Italy. salvatore.chirumbolo@univr.it.
2
Italian Society for Oxygen-Ozone Therapy (SIOOT), High School in Oxygen Ozone Therapy, University of Pavia, Pavia, Italy.
3
Department of Surgery, Dentistry, Paediatrics and Gynaecology-Unit of Maxillo-Facial Surgery, University of Verona, Verona, Italy.
PMID:
33400161
PMCID:
PMC7782567
DOI:
10.1007/s11739-020-02592-w
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Oxygen
Ozone*
Renal Dialysis
SARS-CoV-2
Substances
Ozone
Oxygen